Recruiting NCT07436156
SUMMIT RISE Study of Acute Ischemic Stroke Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Route 92 Medical Reperfusion Systems.
- Who it may be relevant to
- Registry conditions: Acute Ischemic Stroke. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
Overview
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Detailed description
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
Interventions
- Device Route 92 Medical Reperfusion Systems
Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems
Primary outcome measures
- Periprocedural eTICI measurement of revascularization [Time frame: Periprocedural]
Eligibility criteria
Inclusion criteria
- Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
- Informed consent completed and documented within 72 hours following thrombectomy procedure
- Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
- Age ≥ 18 years
Exclusion criteria
- None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Route 92 Medical, Inc. — West Jordan
Identifiers
NCT: NCT07436156 · CIP 4262